Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK&F 95654 in the spontaneously hypertensive rat

Toxicologic Pathology
Jun ZhangF D Sistare

Abstract

The cardiovascular injury of the type III selective PDE inhibitor SK&F 95654 was investigated in SHR. Twenty-four hours after a single sc injection of 100 or 200 mg/kg of the drug, rats exhibited cardiomyocyte necrosis and apoptosis, interstitial inflammation, hemorrhage and edema, as well as mesenteric arterial hemorrhage and necrosis, periarteritis, EC and VSMC apoptosis, EC activation, and MC activation and degranulation. Elevated serum levels of cTnT and decreased cTnT immunoperoxidase staining on cardiomyocytes were detected in the drug-treated rats. Serum levels of alpha2-macroglobulin and IL-6 were significantly elevated following drug treatment. NMR spectral patterns of urine samples are significantly different between the drug-treated and control rats. These results indicate that measurement of serum cTnT, acute phase proteins, and cytokines as well as metabonomic urine profiles may serve as potential biomarkers for drug-induced cardiovascular injury in rats. Increased expression of CD63 on MC (tissue biomarker of MC), of nitrotyrosine on MC and EC (an indirect indicator of NO in vivo), and of iNOS on MC and EC (source of NO) suggest that NO produced by activated and degranulated MC as well as activated EC play an impo...Continue Reading

References

Oct 1, 1978·Environmental Health Perspectives·T Balazs, V J Ferrans
May 1, 1990·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·F R WestwoodP Greaves
Oct 1, 1989·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·G E SanduskyJ R Means
May 1, 1986·Archives of Toxicology·J H HarlemanM S Lamb
Oct 1, 1965·The American Journal of Physiology·H E Weimer, D C Benjamin
Oct 15, 1969·Comparative Biochemistry and Physiology·B K McNab
Nov 12, 1996·Biochemical and Biophysical Research Communications·C C WuM H Yen
Mar 12, 1998·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·T BertschW Rebel
Jun 2, 1998·Kidney International·B J Ballermann
Jan 27, 1999·Methods in Enzymology·L VieraJ S Beckman
Sep 28, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·D G RobertsonT K Braden
Apr 17, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·M LeskinenP T Kovanen
Jun 8, 2001·Journal of Neurotrauma·J XuC Y Hsu
Aug 16, 2002·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Hisashi IkegamiKunio Doi
Sep 6, 2002·Cardiovascular Toxicology·D G RobertsonL A Dethloff
Apr 15, 2003·Toxicology and Applied Pharmacology·Tsung-Ming ShihJohn H McDonough
Jul 17, 2004·International Journal of Experimental Pathology·Catherine S VinenDavid B G Oliveira
Feb 8, 2005·Toxicology and Applied Pharmacology·William KernsUNKNOWN Expert Working Group on Drug-Induced Vascular Injury

❮ Previous
Next ❯

Citations

May 11, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·June K DunnickGregory S Travlos
Oct 17, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sevil KorkmazJean-Louis Freslon
Apr 19, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Christopher M ShethJames L Weaver
Jan 25, 2012·Journal of Toxicologic Pathology·Robert A EttlinDavid E Prentice
Oct 24, 2006·Pharmacogenomics·Laura K Schnackenberg, Richard D Beger
Oct 11, 2011·Toxicology and Applied Pharmacology·Deidre A DalmasHeath C Thomas
Nov 26, 2009·Toxicology and Applied Pharmacology·Richard D BegerLaura K Schnackenberg
Jul 24, 2013·Regulatory Toxicology and Pharmacology : RTP·E A HausnerP Harlow
Oct 10, 2012·Regulatory Toxicology and Pharmacology : RTP·Brian R BerridgeSyril D Pettit
Sep 9, 2016·Toxicologic Pathology·Marcia E Pereira Bacares
Mar 14, 2008·Toxicologic Pathology·Christopher J Clarke, John N Haselden
Apr 30, 2014·Toxicologic Pathology·Igor MikaelianUNKNOWN Vascular Injury Working Group of the Predictive Safety Consortium
May 18, 2007·Clinical Pharmacology and Therapeutics·F D Sistare, J J DeGeorge
Jan 1, 2008·Toxicology Mechanisms and Methods·Laura K Schnackenberg, Richard D Beger
Sep 14, 2016·Journal of Toxicologic Pathology·Brian R BerridgeMonique Y Wells

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
NMR
PCA
light microscopy

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis